Coral Dawn Hanevold
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Coral Dawn Hanevold has a total of 238 co-authors. Here are the top co-authors by number of shared publications:
Joseph T. Flynn
Division of Nephrology, Department of Pediatrics, University of Washington School of Medicine, Seattle, USA
11 shared publicationsLisa J. Martin
Cincinnati Children’s Hospital Medical Center and the University of Cincinnati College of Medicine (R.C.B., L.J.M., M.M., P.K., J. Seo, E.M.U.).
8 shared publicationsGilad Hamdani
Schneider Children’s Medical Center, Petach Tikvah, Israel (G.H.).
7 shared publicationsGregory A. Harshfield
Georgia Prevention Institute, Department of Population Health Sciences, Medical College of Georgia, Augusta University, Augusta, GA
7 shared publicationsMark Mitsnefes
Cincinnati Children's Hospital Medical Center
7 shared publicationsBernard Rosner
Channing Division of Network Medicine, Harvard University
6 shared publications
Latest Publications
- Open Access
- 3 July 2026
- Published by Springer Nature in Research Square
Isolated Nocturnal Hypertension and Target Organ Damage: A SHIP-AHOY Ancillary Study
Background Isolated nocturnal hypertension (INH) and its relationship to target organ damage (TOD) is poorly studied in pediatrics. This study aims to examine the epidemiology of INH in the Study of Hypertension in Pediatrics, Adult Hypertension Onset in Youth (SHIP-AHOY) cohort and its association with TOD. INH is hypothesized to be associated with an increased risk of TOD. Methods Data were obtained from SHIP-AHOY participants. Primary exposure was INH, defined using static thresholds (wake < 130/80, sleep ≥ 110/65) and using the 95th percentile for ambulatory blood pressure (BP). Primary outcome was left ventricular hypertrophy (LVH), defined as left ventricular mass index > 38.6 g/m 2.7 . Logistic regression evaluated the association of INH with LVH, adjusted for age, sex, cardiovascular risk factor score, and BP tolerability. Results Using static thresholds, INH was present in 19.7% of adolescents, 61% due to systolic BP only. Age and height were greater in INH than normotension (16.1v15.4 years, P = 0.008) (168.9v166.4 cm, P = 0.036). Other demographics and anthropometric variables did not significantly differ. INH had lower estimated glomerular filtration rate (96.3v100.3 ml/min/1.73m 2 , P = 0.027). Among INH, 27% (N = 18/68) had LVH. Wake and clinic BPs were higher, but not hypertensive, in INH. INH was associated with a 2.7-fold increase in adjusted odds of LVH compared to normotension (95%CI [1.20,5.93], P = 0.016). Use of 95th percentiles resulted in a lower prevalence of INH (10%) and LVH (19%). Conclusions INH is prevalent and associated with 2.7-fold adjusted odds of LVH compared to normotension in adolescents. Longitudinal studies are needed to characterize long-term implications of INH.
- 3 July 2026
- Published by Springer Nature in Research Square
Open AccessIsolated Nocturnal Hypertension and Target Organ Damage: A SHIP-AHOY Ancillary Study
Background Isolated nocturnal hypertension (INH) and its relationship to target organ damage (TOD) is poorly studied in pediatrics. This study aims to examine the epidemiology of INH in the Study of Hypertension in Pediatrics, Adult Hypertension Onset in Youth (SHIP-AHOY) cohort and its association with TOD. INH is hypothesized to be associated with an increased risk of TOD. Methods Data were obtained from SHIP-AHOY participants. Primary exposure was INH, defined using static thresholds (wake < 130/80, sleep ≥ 110/65) and using the 95th percentile for ambulatory blood pressure (BP). Primary outcome was left ventricular hypertrophy (LVH), defined as left ventricular mass index > 38.6 g/m 2.7 . Logistic regression evaluated the association of INH with LVH, adjusted for age, sex, cardiovascular risk factor score, and BP tolerability. Results Using static thresholds, INH was present in 19.7% of adolescents, 61% due to systolic BP only. Age and height were greater in INH than normotension (16.1v15.4 years, P = 0.008) (168.9v166.4 cm, P = 0.036). Other demographics and anthropometric variables did not significantly differ. INH had lower estimated glomerular filtration rate (96.3v100.3 ml/min/1.73m 2 , P = 0.027). Among INH, 27% (N = 18/68) had LVH. Wake and clinic BPs were higher, but not hypertensive, in INH. INH was associated with a 2.7-fold increase in adjusted odds of LVH compared to normotension (95%CI [1.20,5.93], P = 0.016). Use of 95th percentiles resulted in a lower prevalence of INH (10%) and LVH (19%). Conclusions INH is prevalent and associated with 2.7-fold adjusted odds of LVH compared to normotension in adolescents. Longitudinal studies are needed to characterize long-term implications of INH.
- 1 June 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (6) , 992-1001
Youth Blood Pressure and Target Organ Injury Markers: The SHIP AHOY Study
BACKGROUND: Hypertension in adolescence is associated with subclinical target organ injury. We aimed to determine whether different blood pressure thresholds were associated with an increasing number of target organ injury markers in healthy adolescents. METHODS: A total of 244 participants (mean age 15.5±1.8 years, 60.1% male adolescents) were studied. Participants were divided based on systolic clinic and systolic awake ambulatory blood pressure into low- (90th percentile) groups. The ambulatory blood pressure phenotype was classified as normotensive, white-coat, masked, or sustained hypertension. Target organ injury assessments included left ventricular mass, systolic and diastolic function, and vascular stiffness. A multivariable general linear model was constructed to evaluate the association of different participant characteristics with higher numbers of target organ injury markers. RESULTS: A total of 31.2% of participants had 1, 11.9% 2, 3.7% 3, and 0.8% 4 target organ injury markers. The number of target organ injury markers increased according to the risk groups: the percentage of participants with >1 marker in the low-, mid-, and high-risk groups was 6.7%, 19.1%, and 21.8% ( P =0.02) and 9.6%, 15.8%, and 32.2% ( P 1 target organ injury marker than normotensives (8%, P <0.001). The results were unchanged in multivariate analysis. CONCLUSIONS: High clinic and ambulatory blood pressure values, as well as ambulatory blood pressure phenotypes (white-coat, masked, and sustained hypertension), were independently associated with an increasing number of subclinical cardiovascular injury markers in adolescents.
- 1 June 2025
- Published by Wolters Kluwer Health in Hypertension
- Vol. 82 (6) , 992-1001
Youth Blood Pressure and Target Organ Injury Markers: The SHIP AHOY Study
BACKGROUND: Hypertension in adolescence is associated with subclinical target organ injury. We aimed to determine whether different blood pressure thresholds were associated with an increasing number of target organ injury markers in healthy adolescents. METHODS: A total of 244 participants (mean age 15.5±1.8 years, 60.1% male adolescents) were studied. Participants were divided based on systolic clinic and systolic awake ambulatory blood pressure into low- (90th percentile) groups. The ambulatory blood pressure phenotype was classified as normotensive, white-coat, masked, or sustained hypertension. Target organ injury assessments included left ventricular mass, systolic and diastolic function, and vascular stiffness. A multivariable general linear model was constructed to evaluate the association of different participant characteristics with higher numbers of target organ injury markers. RESULTS: A total of 31.2% of participants had 1, 11.9% 2, 3.7% 3, and 0.8% 4 target organ injury markers. The number of target organ injury markers increased according to the risk groups: the percentage of participants with >1 marker in the low-, mid-, and high-risk groups was 6.7%, 19.1%, and 21.8% ( P =0.02) and 9.6%, 15.8%, and 32.2% ( P 1 target organ injury marker than normotensives (8%, P <0.001). The results were unchanged in multivariate analysis. CONCLUSIONS: High clinic and ambulatory blood pressure values, as well as ambulatory blood pressure phenotypes (white-coat, masked, and sustained hypertension), were independently associated with an increasing number of subclinical cardiovascular injury markers in adolescents.
- 19 May 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (1) , 157-165
Ambulatory blood pressure variability in prediction of target organ injury: the SHIP AHOY study
Background Ambulatory hypertension is associated with elevated left ventricular mass index (LVMI), cardiac dysfunction, and increased arterial stiffness in adolescents. Whether the addition of measures of BP variability improves the prediction of subclinical cardiovascular target organ damage (TOD) over mean BP measures is not known. Methods We assessed clinic and ambulatory BP (ABP), anthropometrics, and TOD in 397 adolescents. ABP means standard deviation (SD), BP, and heart rate (HR) dipping were calculated; coefficients of variability (CV) were calculated (SD/mean) to assess ABP variabilities. Measures of TOD included LVMI, left ventricular hypertrophy (LVH), LV systolic shortening, LV diastolic function (e′/a′), and pulse wave velocity. General linear models were used to determine if increased ABP variability measures were significant determinants of TOD in models containing mean ABP percentiles, age, sex, race/ethnicity, BMI z-score, and HR. Results Mean participant age was 15.6 ± 1.7 years (63% white, 59% male) with mean casual BP 122.6/71.6 mmHg ±12.4/10.5, and mean awake systolic ABP 124.2/72.0 ± 11.3/7.7 mmHg. In linear models, increased awake CV-DBP and HR dipping were significant determinants of LVMI. CV-HR was an independent determinant of diastolic (e′/a′) but not systolic dysfunction. Using logistic regression, the combination of awake and asleep diastolic ABP variability and awake systolic ABP percentile improved the prediction of LVH. Conclusions Consideration of ABP variability in addition to ABP percentile may aid in identifying adolescents at risk for LVH. Graphical abstract A higher resolution version of the Graphical abstract is available as A higher resolution version of the Graphical abstract is available as Supplementary information
- 19 May 2025
- Published by Springer Nature in Pediatric Nephrology
- Vol. 41 (1) , 157-165
Ambulatory blood pressure variability in prediction of target organ injury: the SHIP AHOY study
Background Ambulatory hypertension is associated with elevated left ventricular mass index (LVMI), cardiac dysfunction, and increased arterial stiffness in adolescents. Whether the addition of measures of BP variability improves the prediction of subclinical cardiovascular target organ damage (TOD) over mean BP measures is not known. Methods We assessed clinic and ambulatory BP (ABP), anthropometrics, and TOD in 397 adolescents. ABP means standard deviation (SD), BP, and heart rate (HR) dipping were calculated; coefficients of variability (CV) were calculated (SD/mean) to assess ABP variabilities. Measures of TOD included LVMI, left ventricular hypertrophy (LVH), LV systolic shortening, LV diastolic function (e′/a′), and pulse wave velocity. General linear models were used to determine if increased ABP variability measures were significant determinants of TOD in models containing mean ABP percentiles, age, sex, race/ethnicity, BMI z-score, and HR. Results Mean participant age was 15.6 ± 1.7 years (63% white, 59% male) with mean casual BP 122.6/71.6 mmHg ±12.4/10.5, and mean awake systolic ABP 124.2/72.0 ± 11.3/7.7 mmHg. In linear models, increased awake CV-DBP and HR dipping were significant determinants of LVMI. CV-HR was an independent determinant of diastolic (e′/a′) but not systolic dysfunction. Using logistic regression, the combination of awake and asleep diastolic ABP variability and awake systolic ABP percentile improved the prediction of LVH. Conclusions Consideration of ABP variability in addition to ABP percentile may aid in identifying adolescents at risk for LVH. Graphical abstract A higher resolution version of the Graphical abstract is available as A higher resolution version of the Graphical abstract is available as Supplementary information
- Open Access
- 14 March 2025
- Published by Springer Nature in Current Hypertension Reports
- Vol. 27 (1) , 1-9
Hypertension in Childhood Cancer Survivors: Causes, Screening, and Management
Purpose of Review: Survivors of childhood cancer and hematopoietic cell transplant are at risk for developing chronic health conditions, including hypertension. Studies have identified hypertension as an influential risk factor for late kidney dysfunction and cardiovascular disease in childhood cancer survivors. The overall risk of hypertension depends on the specific cancer treatment, from chemotherapy to surgery to radiation. In this report, we aim to review the main causes of hypertension in childhood cancer survivors, with a focus on newer therapies, as well as the current recommendations for screening and management of hypertension in this patient population. Recent Findings: Novel targeted therapies and immunotherapies are being increasingly used in pediatric cancer treatment, with unclear impact on long-term health. Screening guidelines for hypertension in the survivor population have been issued by various childhood cancer cooperative groups based on best available evidence and expert opinion. Newer studies have focused on individual risk prediction, which may help improve the diagnosis and management of hypertension, particularly in higher-risk individuals. Summary: Despite the importance of hypertension as one of the few modifiable risk factors for cardiovascular and renal health, studies have yet to define optimal blood pressure targets, screening parameters, or management strategies in childhood cancer survivors. Additionally, further studies are needed to demonstrate improvement in outcomes following interventions for hypertension specifically in this patient population.
- 14 March 2025
- Published by Springer Nature in Current Hypertension Reports
- Vol. 27 (1) , 1-9
Open AccessHypertension in Childhood Cancer Survivors: Causes, Screening, and Management
Purpose of Review: Survivors of childhood cancer and hematopoietic cell transplant are at risk for developing chronic health conditions, including hypertension. Studies have identified hypertension as an influential risk factor for late kidney dysfunction and cardiovascular disease in childhood cancer survivors. The overall risk of hypertension depends on the specific cancer treatment, from chemotherapy to surgery to radiation. In this report, we aim to review the main causes of hypertension in childhood cancer survivors, with a focus on newer therapies, as well as the current recommendations for screening and management of hypertension in this patient population. Recent Findings: Novel targeted therapies and immunotherapies are being increasingly used in pediatric cancer treatment, with unclear impact on long-term health. Screening guidelines for hypertension in the survivor population have been issued by various childhood cancer cooperative groups based on best available evidence and expert opinion. Newer studies have focused on individual risk prediction, which may help improve the diagnosis and management of hypertension, particularly in higher-risk individuals. Summary: Despite the importance of hypertension as one of the few modifiable risk factors for cardiovascular and renal health, studies have yet to define optimal blood pressure targets, screening parameters, or management strategies in childhood cancer survivors. Additionally, further studies are needed to demonstrate improvement in outcomes following interventions for hypertension specifically in this patient population.
- 1 December 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (12) , 2444-2453
Systolic Blood Pressure, Cardiovascular Health, and Neurocognition in Adolescents
BACKGROUND: We studied whether increased systolic blood pressure (SBP), as determined by auscultatory SBP, ambulatory SBP, and the number of cardiovascular health risk indicators, are associated with neurocognition in adolescents. METHODS: This cross-sectional study included 365 adolescents (mean age, 15.5 years) from 6 academic medical centers in the United States. The sample was 59.5% male, 52.6% White, with 23.9% of the caregivers having less than or equal to a high school degree. Primary exposures included the following: auscultatory SBP, ambulatory SBP, and the number of cardiovascular risk factors. Neurocognitive outcomes comprised nonverbal IQ, attention, and parent ratings of executive functions. RESULTS: After examining the models for the effects of targeted covariates (eg, maternal education), higher auscultatory SBP was associated with lower nonverbal IQ (β=−1.39; P P P P 2 =0.08–0.09). Higher ambulatory blood pressure sleep SBP also was significantly associated with parent ratings of behavior regulation (β=12.61; P P P <0.01), and all parent ratings of executive functions. CONCLUSIONS: Elevated SBP, even below the hypertension range, and general cardiovascular health are associated with neurocognitive outcomes in adolescents. How these findings might guide clinical care is worthy of additional study.
- 1 December 2024
- Published by Wolters Kluwer Health in Hypertension
- Vol. 81 (12) , 2444-2453
Systolic Blood Pressure, Cardiovascular Health, and Neurocognition in Adolescents
BACKGROUND: We studied whether increased systolic blood pressure (SBP), as determined by auscultatory SBP, ambulatory SBP, and the number of cardiovascular health risk indicators, are associated with neurocognition in adolescents. METHODS: This cross-sectional study included 365 adolescents (mean age, 15.5 years) from 6 academic medical centers in the United States. The sample was 59.5% male, 52.6% White, with 23.9% of the caregivers having less than or equal to a high school degree. Primary exposures included the following: auscultatory SBP, ambulatory SBP, and the number of cardiovascular risk factors. Neurocognitive outcomes comprised nonverbal IQ, attention, and parent ratings of executive functions. RESULTS: After examining the models for the effects of targeted covariates (eg, maternal education), higher auscultatory SBP was associated with lower nonverbal IQ (β=−1.39; P P P P 2 =0.08–0.09). Higher ambulatory blood pressure sleep SBP also was significantly associated with parent ratings of behavior regulation (β=12.61; P P P <0.01), and all parent ratings of executive functions. CONCLUSIONS: Elevated SBP, even below the hypertension range, and general cardiovascular health are associated with neurocognitive outcomes in adolescents. How these findings might guide clinical care is worthy of additional study.
- Open Access
A Multi-Omics Approach to Defining Target Organ Injury in Youth with Primary Hypertension
BACKGROUND: Primary hypertension in childhood tracks into adulthood and may be associated with increased cardiovascular risk. Studies conducted in children and adolescents provide an opportunity to explore the early cardiovascular target organ injury (CV-TOI) in a population free from many of the co-morbid cardiovascular disease risk factors that confound studies in adults. METHODS: Youths (n=132, mean age 15.8 years) were stratified by blood pressure (BP) as low, elevated, and high-BP and by left ventricular mass index (LVMI) as low- and high-LVMI. Systemic circulating RNA, miRNA, and methylation profiles in peripheral blood mononuclear cells and deep proteome profiles in serum were determined using high-throughput sequencing techniques. RESULTS: VASH1 gene expression was elevated in youths with high-BP with and without high-LVMI. VASH1 expression levels positively correlated with systolic BP (r=0.3143, p=0.0034). The expression of hsa-miR-335-5p, one of the VASH1- predicted miRNAs, was downregulated in high-BP with high-LVMI youths and was inversely correlated with systolic BP (r=-0.1891, p=0.0489). GSE1 hypermethylation, circulating PROZ upregulation (log 2 FC=0.61, p=0.0049 and log 2 FC=0.62, p=0.0064), and SOD3 downregulation (log 2 FC=-0.70, p=0.0042 and log 2 FC=-0.64, p=0.010) were observed in youths with elevated BP and high-BP with high-LVMI. Comparing the transcriptomic and proteomic profiles revealed elevated HYAL1 levels in youths displaying high-BP and high-LVMI. CONCLUSIONS: The findings are compatible with a novel blood pressure-associated mechanism that may occur through impaired angiogenesis and extracellular matrix degradation through dysregulation of Vasohibin-1 and Hyaluronidase1 was identified as a possible mediator of CV-TOI in youth with high-BP and suggests strategies for ameliorating TOI in adult-onset primary hypertension.
Open AccessA Multi-Omics Approach to Defining Target Organ Injury in Youth with Primary Hypertension
BACKGROUND: Primary hypertension in childhood tracks into adulthood and may be associated with increased cardiovascular risk. Studies conducted in children and adolescents provide an opportunity to explore the early cardiovascular target organ injury (CV-TOI) in a population free from many of the co-morbid cardiovascular disease risk factors that confound studies in adults. METHODS: Youths (n=132, mean age 15.8 years) were stratified by blood pressure (BP) as low, elevated, and high-BP and by left ventricular mass index (LVMI) as low- and high-LVMI. Systemic circulating RNA, miRNA, and methylation profiles in peripheral blood mononuclear cells and deep proteome profiles in serum were determined using high-throughput sequencing techniques. RESULTS: VASH1 gene expression was elevated in youths with high-BP with and without high-LVMI. VASH1 expression levels positively correlated with systolic BP (r=0.3143, p=0.0034). The expression of hsa-miR-335-5p, one of the VASH1- predicted miRNAs, was downregulated in high-BP with high-LVMI youths and was inversely correlated with systolic BP (r=-0.1891, p=0.0489). GSE1 hypermethylation, circulating PROZ upregulation (log 2 FC=0.61, p=0.0049 and log 2 FC=0.62, p=0.0064), and SOD3 downregulation (log 2 FC=-0.70, p=0.0042 and log 2 FC=-0.64, p=0.010) were observed in youths with elevated BP and high-BP with high-LVMI. Comparing the transcriptomic and proteomic profiles revealed elevated HYAL1 levels in youths displaying high-BP and high-LVMI. CONCLUSIONS: The findings are compatible with a novel blood pressure-associated mechanism that may occur through impaired angiogenesis and extracellular matrix degradation through dysregulation of Vasohibin-1 and Hyaluronidase1 was identified as a possible mediator of CV-TOI in youth with high-BP and suggests strategies for ameliorating TOI in adult-onset primary hypertension.
- 9 March 2024
- Published by Springer Nature in Current Hypertension Reports
- Vol. 26 (6) , 259-271
Screening and Management of Pediatric High Blood Pressure—Challenges to Implementing the Clinical Practice Guideline
Purpose of Review Elevated blood pressure (BP) and hypertension in childhood convey risk for hypertension and cardiovascular events in adulthood. Early recognition of abnormal BPs is key to preventing or lessening this risk. However, the process for making the diagnosis of hypertension is complex, and overall adherence to the 2017 American Academy of Pediatrics Clinical Practice Guidelines (CPG) is poor. We will review obstacles to adherence to the CPG and approaches designed to improve the diagnosis and management of hypertension in children. Recent Findings Baseline data from the multi-center quality improvement intervention, “Boosting Primary Care Awareness and Treatment of Hypertension” (BP-CATCH), demonstrate that childhood hypertension remains underdiagnosed. Other studies confirm a lack of compliance with the process outlined in the CPG. The provision of electronic prompts, coaching, and education results in modest improvements. Summary The combination of embedded medical record tools and education seems to offer the most hope for improvement.
- 9 March 2024
- Published by Springer Nature in Current Hypertension Reports
- Vol. 26 (6) , 259-271
Screening and Management of Pediatric High Blood Pressure—Challenges to Implementing the Clinical Practice Guideline
Purpose of Review Elevated blood pressure (BP) and hypertension in childhood convey risk for hypertension and cardiovascular events in adulthood. Early recognition of abnormal BPs is key to preventing or lessening this risk. However, the process for making the diagnosis of hypertension is complex, and overall adherence to the 2017 American Academy of Pediatrics Clinical Practice Guidelines (CPG) is poor. We will review obstacles to adherence to the CPG and approaches designed to improve the diagnosis and management of hypertension in children. Recent Findings Baseline data from the multi-center quality improvement intervention, “Boosting Primary Care Awareness and Treatment of Hypertension” (BP-CATCH), demonstrate that childhood hypertension remains underdiagnosed. Other studies confirm a lack of compliance with the process outlined in the CPG. The provision of electronic prompts, coaching, and education results in modest improvements. Summary The combination of embedded medical record tools and education seems to offer the most hope for improvement.
- 10 January 2023
- Published by Springer Nature
- p. 461-476
White Coat and Masked Hypertension
- 10 January 2023
- Published by Springer Nature
- p. 229-247
Salt Sensitivity in Childhood Hypertension
- Open Access
- 11 November 2022
- Published by Taylor & Francis in Blood Pressure
- Vol. 32 (1) , 1-2
Letter to the editor
To the Editor,Ambulatory blood pressure monitoring (ABPM) is recommended in the evaluation of sustained blood pressure elevation in children to exclude white coat hypertension (WCH) and thus confir...
- 11 November 2022
- Published by Taylor & Francis in Blood Pressure
- Vol. 32 (1) , 1-2
Open AccessLetter to the editor
To the Editor,Ambulatory blood pressure monitoring (ABPM) is recommended in the evaluation of sustained blood pressure elevation in children to exclude white coat hypertension (WCH) and thus confir...